US and UK guidelines for glucocorticoid-induced osteoporosis: similarities and differences.

被引：30

作者：

Compston J. ^{[1
]}

机构：

[1] Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Box 157, CB2 2QQ, Cambridge

来源：

Current Rheumatology Reports | 2004年 / 6卷 / 1期

关键词：

Bone Mineral Density; Bone Densitometry; Glucocorticoid Therapy; Nandrolone Decanoate; National Osteoporosis Society;

D O I：

10.1007/s11926-004-0085-1

中图分类号：

学科分类号：

摘要：

Osteoporosis is a common and serious complication of glucocorticoid therapy. Recent advances in the epidemiology, pathophysiology, and management of glucocorticoid-induced osteoporosis have stimulated the development of guidelines for the prevention and treatment of this condition. In this report, the updated recommendations of the American College of Rheumatology and guidelines recently produced by the Bone and Tooth Society, National Osteoporosis Society, and Royal College of Physicians in the UK are discussed with respect to their similarities and differences.

引用

页码：66 / 69

页数：3

共 70 条

[11]

van Staa TP(1996)Recommendations for the prevention and reatment of glucocorticoid-induced osteoporosis Arthritis Rheum 39 1791-1801

[12]

Leufkens HGM(1991)The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate Bone Miner 15 72-81

[13]

Cooper C(1997)Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis J Bone Miner Res 12 1700-1707

[14]

van Staa TP(2000)Corticosteroid osteoporosis: practical implications of recent trials J Bone Miner Res 15 7645-7649

[15]

Leufkens HGM(2001)Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds Osteoporos Int 12 989-995

[16]

Cooper C(2002)Oral corticosteroids increase fracture risk independently of BMD Osteoporos Int 13 S14-S14

[17]

Adachi JD(1991)Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study Thorax 46 803-806

[18]

Bensen WG(1985)Microcrystalline hydroxyapatite compound in prevention of bone loss in corticosteroid-treated patients with chronic active hepatitis Postgrad Med J 61 791-796

[19]

Brown J(1999)A prospective study of bone loss and turnover after cardiac transplantation: effect of calcium supplementation with or without calcitonin Osteoporos Int 10 128-136

[20]

Saag KG(2000)Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy: a randomized, double-blind, placebo controlled study J Rheumatol 27 1759-1765

← 1 2 3 4 5 6 7 →